Roche persists with Illumina chase
Swiss pharma sent its third letter to Illumina shareholders repeating its readiness to improve its $ 51 a share takeover offer
FT.com – European companies
Roche persists with Illumina chase
Swiss pharma sent its third letter to Illumina shareholders repeating its readiness to improve its $ 51 a share takeover offer
FT.com – European companies
